Abstract:Vast emerging evidences are linking the base modifications and determination of stem cell fate such as proliferation and differentiation. Among the base modification markers extensively studied, 5-methylcytosine (5-mC) and its oxidative derivatives (5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC)) dynamically occur in DNA and RNA and have been acknowledged as important epigenetic markers involved in regulation of cellular biological processes. N6-Methyladenosine modification in DNA (m6dA), mRNA (m6A), tRNA, and other noncoding RNAs has been defined as another important epigenetic and epitranscriptomic marker in eukaryotes in recent years. The mRNA m6A modification has been characterized biochemically, molecularly, and phenotypically, including elucidation of its methyltransferase complexes (m6A writer), demethylases (m6A eraser), and direct interaction proteins (readers), while limited information on the DNA m6dA is available. The levels and the landscapes of m6A in the epitranscriptomes and epigenomes are precisely and dynamically regulated by the fine-tuned coordination of the writers and erasers in accordance with stages of the growth, development, and reproduction as naturally programmed during the lifespan. Additionally, progress has been made in appreciation of the link between aberrant m6A modification in stem cells and diseases, like cancers and neurodegenerative disorders. These achievements are inspiring scientists to further uncover the epigenetic mechanisms for stem cell development and to dissect pathogenesis of the multiple diseases conferred by development aberration of the stem cells. This review article will highlight the research advances in the role of m6A methylation modifications of DNA and RNA in the regulation of stem cell and genesis of the closely related disorders. Additionally, this article will also address the research directions in the future.

M(6)a RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells.

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

Role of N6-methyl-adenosine Modification in Mammalian Embryonic Development

The regulatory role of m 6 A modification in the maintenance and differentiation of embryonic stem cells

m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency

N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate

RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness

The N6-Methyladenosine RNA modification in pluripotency and reprogramming

N 6 -Methyladenosine Modification-Mediated Mrna Metabolism is Essential for Human Pancreatic Lineage Specification and Islet Organogenesis

Epitranscriptomic M6a Modification in the Stem Cell Field and Its Effects on Cell Death and Survival.

Rna Modification N-6-Methyladenosine in Post-Transcriptional Regulation

N6-Methyladenosine Methyltransferases and Demethylases: New Regulators of Stem Cell Pluripotency and Differentiation

The Roles of RNA N6-Methyladenosine in Regulating Stem Cell Fate

Targeted RNA <i>N</i><SUP>6</SUP>-Methyladenosine Demethylation Controls Cell Fate Transition in Human Pluripotent Stem Cells

Steering pluripotency and differentiation with N6-methyladenosine RNA modification

RNA m6A modification regulates cell fate transition between pluripotent stem cells and 2-cell-like cells

Regulation of RNA N6-methylation of adenosine on stem cell differentiation

Dynamic and reversible RNA N6‐methyladenosine methylation

Genetic Regulation of N6-Methyladenosine-RNA in Mammalian Gametogenesis and Embryonic Development

A Programmable System to Methylate and Demethylate N6-methyladenosine (m6a) on Specific RNA Transcripts in Mammalian Cells

RNA M6a Modification Plays a Key Role in Maintaining Stem Cell Function in Normal and Malignant Hematopoiesis